Endo International plc
DelistedCIK 1593034fmd_0ZSCCPCEQTFMMQJXMYEENAW498Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Dec 31, 2023, 45 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 2,381 | 3,269 | 4,010 | 3,469 | 2,947 | 2,914 | 2,903 | 2,993 | 2,319 | 2,012 |
| Cost of revenue | 1,231 | 2,076 | 2,635 | 2,229 | 1,632 | 1,569 | 1,443 | 1,221 | 1,092 | 946 |
| Net interest income | (227) | (373) | (453) | (488) | (522) | (539) | – | – | – | – |
| Gross profit | 1,149 | 1,193 | 1,375 | 1,240 | 1,315 | 1,345 | 1,461 | 1,772 | 1,226 | 1,065 |
| Research and development | 113 | 102 | 183 | 172 | 186 | 131 | 126 | 123 | 128 | 115 |
| Selling, general and administrative | 568 | 741 | 771 | 630 | 646 | 632 | 699 | 862 | 777 | 568 |
| Operating income | 326 | (933) | (3,472) | (960) | (469) | – | – | – | – | – |
| Interest expense | – | – | – | – | 522 | 539 | 533 | 562 | 350 | 0 |
| Other non-operating income (expense) | 32 | (64) | 0 | 17 | 52 | (17) | 21 | 20 | 34 | 10 |
| Income before taxes | 100 | (1,438) | (3,924) | (1,483) | (939) | (345) | (27) | (547) | (2,888) | (2,392) |
| Income tax expense | 38 | (1,137) | (700) | (250) | 23 | 16 | (274) | 22 | 22 | 56 |
| Net income from continuing operations | 62 | (300) | (3,224) | (1,233) | (962) | (361) | 247 | (569) | (2,910) | (2,448) |
| Net income | (721) | (1,495) | (3,347) | (2,035) | (1,031) | (423) | 184 | (613) | (2,923) | (2,450) |